lobbying_activities: 1085762

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1085762	8ed6768a-c97a-47ae-a0ad-178359dd5b01	Q1	AMERICAN PHARMACISTS ASSOCIATION	3071	AMERICAN PHARMACISTS ASSOCIATION	2011	first_quarter	PHA	Pharmacist Loan Repayment Eligibility Act of 2011 (S.48) (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: FDA-2011-D-0074-0001) Draft Guidance for Industry on Medication Guides; Availability: Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies; Availability (Docket Number: FDA-2010-N-0633) Determination of System Attributes for Tracking and Tracing of Prescription Drugs; Public Workshop (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: FDA2011N0100) Drugs for Human Use; Unapproved and Misbranded Oral Drugs Labeled for Prescription Use and Offered for Relief of Symptoms of Cold, Cough, or Alergy; Enforcement Action Dates (Docket Number: FDA-2011-N-0002) Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting Concept - Standardizing REMS programs, components and development of a potential tiered REMS System Concept - Designing Pilot Programs to Distribute Patient Medication Information Concept - Drug Disposal Concept - Preventing counterfeit prescription drugs from entering the supply chain	Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		187231	0	0	2011-04-19T13:40:18.277000-04:00